Skye Bioscience, Inc. (SKYE)
1.775
-0.18
(-8.97%)
USD |
NASDAQ |
Aug 28, 16:00
1.93
+0.16
(+8.73%)
After-Hours: 20:00
Skye Bioscience Total Return Price : 1.775 for Aug. 28, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| August 28, 2026 | 1.775 |
| August 27, 2026 | 1.95 |
| August 26, 2026 | 2.02 |
| August 25, 2026 | 2.015 |
| August 24, 2026 | 2.17 |
| August 21, 2026 | 2.24 |
| August 20, 2026 | 2.243 |
| August 19, 2026 | 2.447 |
| August 18, 2026 | 2.872 |
| August 17, 2026 | 3.321 |
| August 14, 2026 | 4.012 |
| August 13, 2026 | 4.328 |
| August 12, 2026 | 4.391 |
| August 11, 2026 | 4.327 |
| August 10, 2026 | 4.26 |
| August 07, 2026 | 4.155 |
| August 06, 2026 | 3.774 |
| August 05, 2026 | 4.494 |
| August 04, 2026 | 4.60 |
| August 03, 2026 | 4.674 |
| July 31, 2026 | 4.548 |
| July 30, 2026 | 4.642 |
| July 29, 2026 | 4.92 |
| July 28, 2026 | 4.919 |
| July 27, 2026 | 4.982 |
| Date | Value |
|---|---|
| July 24, 2026 | 5.215 |
| July 23, 2026 | 5.40 |
| July 22, 2026 | 5.122 |
| July 21, 2026 | 5.12 |
| July 20, 2026 | 5.230 |
| July 17, 2026 | 5.194 |
| July 16, 2026 | 5.029 |
| July 15, 2026 | 4.849 |
| July 14, 2026 | 4.961 |
| July 13, 2026 | 5.296 |
| July 10, 2026 | 5.52 |
| July 09, 2026 | 5.607 |
| July 08, 2026 | 5.624 |
| July 07, 2026 | 5.626 |
| July 06, 2026 | 5.626 |
| July 02, 2026 | 5.604 |
| July 01, 2026 | 5.402 |
| June 30, 2026 | 5.546 |
| June 29, 2026 | 5.364 |
| June 26, 2026 | 5.439 |
| June 25, 2026 | 5.667 |
| June 24, 2026 | 5.432 |
| June 23, 2026 | 5.60 |
| June 22, 2026 | 5.670 |
| June 18, 2026 | 5.658 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Regeneron Pharmaceuticals, Inc. | 794.19 |
| Viking Therapeutics, Inc. | 32.16 |
| ACADIA Pharmaceuticals, Inc. | 29.11 |
| Alnylam Pharmaceuticals, Inc. | 237.10 |
| Anika Therapeutics, Inc. | 21.10 |